ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
WEP Clinical
This is an unsolicited application to WEP, a fast-growing team, indicating interest in potential employment opportunities. The job description does not specify a particular role, responsibilities, or skills.
Headquarters
London, England, United Kingdom
Company Size
51-200 employees
Founded
2008
WEP Clinical is a full-service, "Complete CRO" built for biotech sponsors, offering bespoke services across the full lifecycle of drug development. They deliver clinical trial management (Phase I–IV) and complementary Treatment Access, Market Access and Commercialization solutions to help sponsors advance medicines and reach patients worldwide. With a proven track record supporting 60+ clinical programs globally, WEP focuses on tailored strategies to accelerate development, access and launch.
Business WireWEP Clinical Acquires Netherlands-Based CRO Siron Clinical, Expanding Global Phase I–IV Trial Delivery Capabilities
1 month ago
European AIDS Treatment GroupWEP Clinical has partnered with Theratechnologies to launch a Named Patient Program for EGRIFTA SV®
Aug 8, 2023
Clinical LeaderContinuing Rare Disease Treatment With A Compassionate Use Program (CUP)
Oct 2, 2024
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for WEP Clinical .
European AIDS Treatment GroupWEP Clinical has partnered with TaiMed Biologics to launch a Trogarzo named patient program
Mar 27, 2023
